Myomas are the most frequent benign neoplasias of the female
reproductive system. They probably occur in about 20–40% of all
women of reproductive age [1]. In more precise processing of
hysterectomy preparations, leiomyomas of various sizes are found
in up to 80% [2]. Most myomas are asymptomatic and do not need
any treatment. Yet 20–50% of women with myomas have
complaints that encroach upon their quality-of-life and make
treatment necessary [3]. The following symptoms can typically be
caused by myomas: heavy and prolonged menstrual bleeding,
dysmenorrhea, dyspareunia, feelings of pressure or foreign bodies
in the underbelly, and bladder pressure [4,5].
These myoma-associated complaints have negative effects on
both the quality-of-life and the ability to work of the affected
patients, and they are associated with an increased utilization of the
healthcare system [6,7]. Patients with similar or identical myoma
pathology findings report different complaints, individually